Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -476.39% is 191% below its 5-year average of -163.85%, around the middle of its 5-year range (-1275.46%–-17.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.03% above its 12-month average of -661.91%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -476.39%.
RETURN ON INVESTED CAPITAL (ROIC)
-476.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-661.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-313.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-163.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+28.03%
CURRENT VS 3Y AVG
-52.07%
CURRENT VS 5Y AVG
-190.74%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.63%
median of 829 covered companies
CURRENT VS SECTOR MEDIAN
-1237.04%
vs the sector median at left
iSpecimen Inc.
Market Cap
$2.77M
Return on Invested Capital (ROIC)
-476.39%
TTM Avg
-661.91%
3Y Avg
-313.26%
5Y Avg
-163.85%
Market Cap
$2.84M
Return on Invested Capital (ROIC)
-4.46%
TTM Avg
-9.72%
3Y Avg
-10.30%
5Y Avg
1.55%
Market Cap
$2.62M
Return on Invested Capital (ROIC)
-238.32%
TTM Avg
-241.12%
3Y Avg
-206.72%
5Y Avg
-167.10%
Market Cap
$2.54M
Return on Invested Capital (ROIC)
-237.93%
TTM Avg
-187.67%
3Y Avg
-136.08%
5Y Avg
-136.08%
Market Cap
$3.01M
Return on Invested Capital (ROIC)
-464.86%
TTM Avg
-2260.77%
3Y Avg
-1213.54%
5Y Avg
-842.71%
Market Cap
$3.04M
Return on Invested Capital (ROIC)
-75.31%
TTM Avg
-107.77%
3Y Avg
-224.28%
5Y Avg
-195.58%
Market Cap
$2.50M
Return on Invested Capital (ROIC)
-286.46%
TTM Avg
-159.21%
3Y Avg
-198.72%
5Y Avg
-198.72%
Market Cap
$3.06M
Return on Invested Capital (ROIC)
-104.28%
TTM Avg
-131.89%
3Y Avg
-356.58%
5Y Avg
-286.34%
Market Cap
$2.47M
Return on Invested Capital (ROIC)
-110.81%
TTM Avg
-123.52%
3Y Avg
-108.42%
5Y Avg
-102.13%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| iSpecimen Inc. (ISPC) | $2.77M | -476.39% | -661.91% | -313.26% | -163.85% |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.84M | -4.46% | -9.72% | -10.30% | 1.55% |
| Nuwellis, Inc. (NUWE)vs › | $2.62M | -238.32% | -241.12% | -206.72% | -167.10% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | -237.93% | -187.67% | -136.08% | -136.08% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.01M | -464.86% | -2260.77% | -1213.54% | -842.71% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | -75.31% | -107.77% | -224.28% | -195.58% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.50M | -286.46% | -159.21% | -198.72% | -198.72% |
| Revelation Biosciences, Inc. (REVB)vs › | $3.06M | -104.28% | -131.89% | -356.58% | -286.34% |
| Jaguar Health, Inc. (JAGX)vs › | $2.47M | -110.81% | -123.52% | -108.42% | -102.13% |
| IceCure Medical Ltd (ICCM)vs › | $3.12M | -184.27% | -194.39% | -144.44% | -112.27% |
ROIC
-476.4%
ROE
-657.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -476.39% |
| 2026-03-31 | -924.01% |
| 2025-12-31 | -272.05% |
| 2025-09-30 | -361.66% |
| 2025-06-30 | -1275.46% |
| 2025-03-31 | -590.90% |
| 2024-12-31 | -355.55% |
| 2024-09-30 | -166.52% |
| 2024-06-30 | -168.28% |
| 2024-03-31 | -170.66% |
| 2023-12-31 | -114.32% |
| 2023-09-30 | -81.70% |
| 2023-06-30 | -77.13% |
| 2023-03-31 | -57.34% |
| 2022-12-31 | -50.09% |
| 2022-09-30 | -38.73% |
| 2022-06-30 | -28.97% |
| 2022-03-31 | -23.50% |
| 2021-12-31 | -17.84% |
| 2021-09-30 | -31.35% |
| 2021-06-30 | -30.18% |
